Patent · US Active

Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger RNA

US10801066B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Assignee

American University of Beirut · LB

Inventors

Kamal F. Badr · Nashville, US
Assaad Eid · Paris, FR
Robert Habib · Geneva, CH

Key dates

Filing date	Sep 8, 2015
Grant date	Oct 13, 2020
Priority date	—
Expiry date	Jan 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.